...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of the advanced practitioner in oncology >Management of Advanced Bladder Cancer: An Update
【24h】

Management of Advanced Bladder Cancer: An Update

机译：晚期膀胱癌的管理：更新

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Bladder cancer is the sixth most common cancer in the United States; therefore, the majority of clinicians working in the oncology setting will care for this patient population. Unfortunately, treatment plans, especially in the advanced setting, lack consistency. This, along with the advanced age and comorbidities of most bladder cancer patients, can provide challenges for clinicians when developing treatment plans. In the past 2 years, new drug approvals, specifically those for immune checkpoint inhibitors, have changed the treatment landscape for bladder cancer for the first time since the 1980s. This review article outlines the current management for muscle-invasive and metastatic bladder cancer, while also highlighting future considerations in this disease space. It is imperative that oncology advanced practice providers are up to date with these new changes and have a sound understanding of treatment principles for patients with advanced bladder cancer in order to deliver the safest and most effective care.
机译：膀胱癌是美国的第六次常见的癌症;因此，在肿瘤环境中工作的大多数临床医生将关心这种患者人口。不幸的是，治疗计划，特别是在先进的环境中，缺乏一致性。这与大多数膀胱癌患者的高龄和可血糖一起，在制定治疗计划时可以为临床医生提供挑战。在过去的两年里，新的药物批准，特别是免疫检查点抑制剂的审批，自20世纪80年代以来的第一次改变了膀胱癌的治疗景观。本综述文章概述了肌肉侵入性和转移性膀胱癌的当前管理，同时还突出了该疾病空间的未来考虑因素。肿瘤学高级实践提供者必须与这些新的变化最新，并对治疗晚期膀胱癌的患者进行治疗原则，以便提供最安全，最有效的护理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号